Fund infusion critical to sustaining operations of the firm over medium term, say analysts
Weak consumer sentiment, higher inflation is hurting sales
Street is bearish on exporters while there is a mixed opinion on the consumption basket
Any proposal to boost manufacturing, demand would help sector and listed companies
Q3 witnessed weak volumes; valuations do not factor in risks
Strong realisations helped the company beat estimates in Q3
A lot hinges on its ability to boost volumes amid stiff competition
Weak margin trajectory of the FMEG segment and valuations could limit upside
Margins too should move up as the proportion of these segments improves in the revenue mix
While Q3 performance beat Street estimates, O2C is key to sustaining growth this year
Brokerages cut earnings given pressure on margins but see stock performing in long term
It is expected to support its rich valuations
Near-term growth concerns, too, weighed on the stock
Q3 could see weak volumes; hurdle for incumbents is new entrants in the sector
Market share gains in the Indian market and margin expansion are other positives
Margins expected to bottom out; brokerages prefer category leaders
Brokerages are neutral on the stock given near term challenges and valuations
Higher sales, improving cash flows are expected to drive further debt reduction for the sector
Kotak Institutional Equities believes that Q3 for speciality chemicals will be a mixed bag, with weak earnings from most players in the crop protection space
The quarterly update indicates strong sales momentum across geographies